| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |